All Pathways
PediatricsEmergency

Pediatric Acute Asthma Exacerbation (GINA 2025)

Pediatric Acute Asthma Exacerbation (GINA 2025): Pediatric Acute Asthma Exacerbation → Assess Severity → Mild-Moderate Treatment → Response After 1 Hour...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Pediatric Acute Asthma Exacerbation

    Child with acute wheeze/dyspnea

    1. Action

      Assess Severity

      Clinical assessment

      • MILD-MODERATE:
      • • Talks in phrases, prefers sitting
      • • Not agitated, SpO2 ≥92%
      • • HR increased but not severe
      • SEVERE:
      • • Talks in words only, sits hunched forward
      • • Agitated, SpO2 <92%
      • • Accessory muscle use, RR >30
      • LIFE-THREATENING:
      • • Silent chest, cyanosis, exhaustion
      • • Altered consciousness, SpO2 <90%
      1. Action

        Mild-Moderate Treatment

        Initial bronchodilator therapy

        • SABA: Salbutamol (albuterol)
        • • pMDI + spacer: 4-6 puffs
        • • OR nebulizer: 2.5 mg (5 mg if >40 kg)
        • • Repeat every 20 min x3 in first hour
        • ORAL CORTICOSTEROID:
        • • Prednisolone 1-2 mg/kg (max 40 mg)
        • • Give within first hour
        • Maintain SpO2 ≥94% (≥92% for age ≥12)
        1. Decision

          Response After 1 Hour?

          Reassess after initial treatment

          1. Outcome

            Good Response

            Improving - consider discharge

            • Observe 1-2 hours
            • SpO2 ≥94% on room air
            • PEF/FEV1 ≥60-80% predicted
            • DISCHARGE WITH:
            • • Continue SABA q3-4h prn
            • • Oral prednisolone 3-5 days
            • • Review ICS adherence
            • • Follow-up within 1-2 weeks
          2. Action

            Poor Response

            Escalate therapy

            • Continue SABA q1h or continuous neb
            • Continue ipratropium q4-6h
            • ADD MAGNESIUM SULFATE IV:
            • • 25-50 mg/kg (max 2 g)
            • • Infuse over 20-30 minutes
            • • Single dose (may repeat once)
            • Consider high-flow nasal cannula
            • ICU consultation if not improving
            1. Outcome

              Admit to Hospital

              Criteria for admission

              • SpO2 <92% on room air
              • Requiring ongoing O2/frequent SABA
              • Poor response to initial treatment
              • Previous severe exacerbations
              • Unable to take oral steroids
              • Inadequate home support
            2. Warning

              Life-Threatening/ICU

              Critical care required

              • IMMEDIATE:
              • • Nebulized SABA continuous
              • • Ipratropium + magnesium sulfate IV
              • • IV corticosteroids
              • CONSIDER:
              • • IV salbutamol 5-15 mcg/kg loading, then 1-5 mcg/kg/min
              • • Aminophylline (limited evidence)
              • • BiPAP or intubation if failing
              • • Ketamine for intubation
              • AVOID: Aggressive sedation, high PEEP
      2. Action

        Severe Exacerbation

        Intensive initial treatment

        • SABA: Salbutamol continuous/q20min
        • • 2.5-5 mg neb back-to-back x3
        • ADD IPRATROPIUM:
        • • 250-500 mcg neb with SABA
        • • For first hour (3 doses)
        • OXYGEN: Target SpO2 94-98%
        • SYSTEMIC STEROIDS:
        • • Prednisolone 1-2 mg/kg PO (max 40 mg)
        • • OR Methylprednisolone 1-2 mg/kg IV

Guideline Source

GINA 2025 - Global Strategy for Asthma Management

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Different management for children ≤5 years
  • Does not address maintenance therapy

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Pediatric Acute Asthma Exacerbation (GINA 2025)?

The Pediatric Acute Asthma Exacerbation (GINA 2025) is a emergency clinical algorithm for Pediatrics. It provides a structured decision tree to guide clinical decision-making, based on GINA 2025 - Global Strategy for Asthma Management.

What guideline is the Pediatric Acute Asthma Exacerbation (GINA 2025) based on?

This algorithm is based on GINA 2025 - Global Strategy for Asthma Management.

What are the limitations of the Pediatric Acute Asthma Exacerbation (GINA 2025)?

Known limitations include: Different management for children ≤5 years; Does not address maintenance therapy. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Pediatric Acute Asthma Exacerbation (GINA 2025) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free